NCT03215667

Brief Summary

Purpose of the single arm study is to clinically and histologically evaluate alloplastic in-situ hardening, moldable beta-tricalcium phosphate(TCP) bone graft material and polylactide membrane in alveolar ridge preservation following extraction of non-molar teeth with non-containable extraction sockets.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 10, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 12, 2017

Completed
20 days until next milestone

Study Start

First participant enrolled

August 1, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 3, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 3, 2019

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

January 25, 2021

Completed
Last Updated

January 25, 2021

Status Verified

January 1, 2021

Enrollment Period

2.3 years

First QC Date

July 10, 2017

Results QC Date

December 28, 2020

Last Update Submit

January 22, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Radiographic Measurements of Bone Ridge Dimensions

    Cone-beam computed tomography (CBCT) was taken at the ridge preservation procedure (baseline) and 3 months after the procedure. The horizontal ridge width was measured at 1, 3, 5 and 7 mm below the alveolar bone crest. Overall change is the average of all measurements.

    Change from Baseline at 3 months

Secondary Outcomes (1)

  • Change in Digital Measurements of Soft Tissue Dimensions

    Change from baseline at 5 months

Study Arms (1)

Device treatment

EXPERIMENTAL

easy-graft CLASSIC (beta-Tricalcium Phosphate) grafting covered with polylactide membrane

Device: easy-graft CLASSIC (beta-Tricalcium Phosphate)

Interventions

easy-graft will be grafted to a single extraction socket and covered by polylactide membrane to facilitate regeneration of new bone in order to preserve alveolar ridge dimensions.

Also known as: GUIDOR Bioresorbable Matrix Barrier
Device treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adequate restorative space for a dental implant restoration, if the subject decides previous to study participation that they would like an implant. Note, agreement to implant placement is not a requirement of the study
  • minimum of 10-mm vertical bone without impinging on adjacent vital structures (Maxillary sinus, neurovascular bundles)
  • single-rooted tooth to be extracted
  • American Society of Anesthesiologists (ASA) Physical Status Classification I or II
  • age \>18 years old
  • subjects who had \>50% of height on any portion on the buccal wall of dehiscence and/or fenestration of the extraction socket following extraction will be included from this study
  • adjacent teeth to extraction site will be present during healing period
  • willingly sign informed consent and authorization.

You may not qualify if:

  • pregnancy or nursing woman
  • subjects with active systemic or localized infection (exclude chronic periodontitis)
  • subjects with a history of any medical conditions that contraindicated or weighed against dental implant placement such as history of bisphosphonate drug use, chemotherapeutic or immunosuppressive agents, autoimmune disease, or poorly controlled diabetes (HBA1c\>7%)
  • subjects with smoking habit (more than 10 cigarettes per day)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University School of Dentistry

Indianapolis, Indiana, 46202, United States

Location

Results Point of Contact

Title
Akane Takemura
Organization
Sunstar Americas, Inc.

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2017

First Posted

July 12, 2017

Study Start

August 1, 2017

Primary Completion

November 3, 2019

Study Completion

November 3, 2019

Last Updated

January 25, 2021

Results First Posted

January 25, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations